PSMKX
Price
$51.78
Change
-$0.11 (-0.21%)
Updated
Sep 20 closing price
RPTIX
Price
$109.40
Change
-$0.77 (-0.70%)
Updated
Sep 20 closing price
Ad is loading...

PSMKX vs RPTIX

Header iconPSMKX vs RPTIX Comparison
Open Charts PSMKX vs RPTIXBanner chart's image
Pioneer Select Mid Cap Growth K
Price$51.78
Change-$0.11 (-0.21%)
VolumeN/A
CapitalizationN/A
T. Rowe Price Mid-Cap Growth I
Price$109.40
Change-$0.77 (-0.70%)
VolumeN/A
CapitalizationN/A
View a ticker or compare two or three
PSMKX vs RPTIX Comparison Chart
Loading...
VS
PSMKX vs. RPTIX commentary
Sep 21, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PSMKX is a Buy and RPTIX is a StrongBuy.

FUNDAMENTALS
Fundamentals
RPTIX has more cash in the bank: 31.4B vs. PSMKX (1.46B). RPTIX pays higher dividends than PSMKX: RPTIX (0.18) vs PSMKX (0.00). PSMKX was incepted earlier than RPTIX: PSMKX (10 years) vs RPTIX (9 years). PSMKX is a more actively managed with annual turnover of: 72.00 vs. RPTIX (21.70). RPTIX has a lower initial minimum investment than PSMKX: RPTIX (500000) vs PSMKX (5000000). PSMKX annual gain was more profitable for investors over the last year : 34.43 vs. RPTIX (14.81). PSMKX return over 5 years is better than : 18.47 vs. RPTIX (15.09).
PSMKXRPTIXPSMKX / RPTIX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence10 years9 years-
Gain YTD17.3459.127190%
Front LoadN/AN/A-
Min. Initial Investment50000005000001,000%
Min. Initial Investment IRAN/AN/A-
Net Assets1.46B31.4B5%
Annual Yield % from dividends0.000.18-
Returns for 1 year34.4314.81232%
Returns for 3 years-15.97-13.57118%
Returns for 5 years18.4715.09122%
Returns for 10 yearsN/AN/A-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CLH246.88-0.54
-0.22%
Clean Harbors
TOI0.29N/A
-0.58%
Oncology Institute (The)
CINT6.59-0.04
-0.60%
CI&T
CSTM16.22-0.54
-3.22%
Constellium SE
KTTA4.43-0.37
-7.71%
Pasithea Therapeutics Corp